Hormone Therapy Insights

A groundbreaking study revealed the complexities of hormone replacement therapy, particularly the effects of estrogen on breast cancer risk. While there was a reported 25% increased risk in one group, the absolute risk remained low. Additionally, starting hormone therapy between ages 50 and 59 showed a significant decrease in cardiovascular disease risk, highlighting the nuanced benefits and risks of estrogen therapy for women.